Publikationen von B. Müller-Myhsok
Alle Typen
Zeitschriftenartikel (387)
381.
Zeitschriftenartikel
130B (1), S. 67 - 68 (2004)
Polymorphisms in serotonin receptor genes HTR1B, HTR2A, HTR2C and HTR4 are possibly associated with specific personality traits in patients suffering from anxiety disorders. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 382.
Zeitschriftenartikel
62 (9), S. 1619 - 1622 (2004)
Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology 383.
Zeitschriftenartikel
36, S. 1319 - 1325 (2004)
Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nature Genetics 384.
Zeitschriftenartikel
74 (1), S. 11 - 19 (2004)
The PARK8 locus in autosomal dominant parkinsonism: Confirmation of linkage and further delineation of the disease-containing interval. American Journal of Human Genetics 385.
Zeitschriftenartikel
36 (5), S. 239 - 239 (2003)
Is there a genetic continuum between anxiety and depression? Pharmacopsychiatry 386.
Zeitschriftenartikel
36 (5), S. 252 - 253 (2003)
HPA axis dysregulation and suicidal behavior in depression - Differentiation of a genetically distinct subgroup? Pharmacopsychiatry 387.
Zeitschriftenartikel
36 (5), S. 273 - 273 (2003)
Evidence for genetic heterogeneity in Restless Legs Syndrome. Pharmacopsychiatry Buchkapitel (3)
388.
Buchkapitel
Statistical genetics: genome-wide studies. In: Psychiatric genetics: a primer for clinical and basic scientists, S. 57 - 69 (Hg. Schulze, T. G.; McMahon, F. J.). Oxford Univ. Press, New York (2018)
389.
Buchkapitel
From Epigenetic Associations to Biological and Psychosocial Explanations in Mental Health. In: NEUROEPIGENETICS AND MENTAL ILLNESS, S. 299 - 323 (Hg. Rutten, B. P. F.). ELSEVIER ACADEMIC PRESS, Cambridge (2018)
390.
Buchkapitel
Genetische Grundlagen der Wirksamkeit von Antidepressiva. Forschungsbericht 2006 - Max-Planck-Institut für Psychiatrie. In: Jahrbuch (Hg. Max-Planck-Gesellschaft). Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., München (2006)
Konferenzbeitrag (9)
391.
Konferenzbeitrag
42 (7), 41, S. 701 - 702 (2018)
How well can we classify coronary artery disease using all genetic data and choosing the best classification algorithm? 27th Annual Meeting of the International Genetic Epidemiology Society (IGES), San Diego, USA, 14. Oktober 2018 - 16. Oktober 2018. GENETIC EPIDEMIOLOGY 392.
Konferenzbeitrag
27 (S3), S. S395 - S396 (2017)
USING POLYGENIC SCORES BASED ON SCHNEIDERIAN FIRST RANK SYMPTOMS TO CHARACTERIZE DISEASE TRAJECTORIES IN SEVERE MENTAL ILLNESSES. 24th World Congress of Psychiatric Genetics (WCPG 2016), Jerusalem, ISRAEL, 30. Oktober 2016 - 04. November 2016. EUROPEAN NEUROPSYCHOPHARMACOLOGY 393.
Konferenzbeitrag
27 (S3), M28, S. S385 - S386 (2017)
POLYGENIC RISK FOR BIP, MDD, AND SCZ IN ANDALUSIAN MULTIPLEX FAMILIES. 24th World Congress of Psychiatric Genetics (WCPG), Jerusalem, ISRAEL, 30. Oktober 2016 - 04. November 2016. EUROPEAN NEUROPSYCHOPHARMACOLOGY 394.
Konferenzbeitrag
27 (S3), S. S486 - S486 (2017)
POLYGENIC SCORES DERIVED FROM NEUROIMAGING ENDOPHENOTYPES PREDICT OUTCOMES TO PSYCHOTHERAPY AND MEDICATION TREATMENTS FOR MAJOR DEPRESSIVE DISORDER. 24th World Congress of Psychiatric Genetics (WCPG), Jerusalem, ISRAEL, 30. Oktober 2016 - 04. November 2016. EUROPEAN NEUROPSYCHOPHARMACOLOGY 395.
Konferenzbeitrag
27 (Suppl.2), Su19, S. S217 - S218 (2017)
GENOME-WIDE ASSOCIATION STUDY OF PANIC DISORDER. 23rd Annual World Congress of Psychiatric Genetics (WCPG), Toronto, CANADA, 16. Oktober 2015 - 20. Oktober 2015. EUROPEAN NEUROPSYCHOPHARMACOLOGY 396.
Konferenzbeitrag
27 (Suppl. 3), T24, S. S446 - S447 (2017)
SEX-SPECIFIC DNA METHYLATION SIGNATURES IN PANIC DISORDER. 24th World Congress of Psychiatric Genetics (WCPG), Jerusalem, ISRAEL, 30. Oktober 2016 - 04. November 2016. EUROPEAN NEUROPSYCHOPHARMACOLOGY 397.
Konferenzbeitrag
27 (Suppl. 2), Sa68, S. S183 - S184 (2017)
IDENTIFICATION OF GENETIC INTERACTIONS INVOLVED IN DYSLEXIA PATHOGENESIS. 23rd Annual World Congress of Psychiatric Genetics (WCPG), Toronto, CANADA, 16. Oktober 2015 - 20. Oktober 2015. EUROPEAN NEUROPSYCHOPHARMACOLOGY 398.
Konferenzbeitrag
124 (10), S. 1292 - 1292 (2017)
Aging- and stress-related epigenetic disinhibition of FKBP5 contributes to NF-κB-driven inflammation and cardiovascular risk. Conference of the World-Association-for-Stress-Related-and-Anxiety-Disorders (WASAD), Würzburg, Germany, 14. September 2017 - 16. September 2017. JOURNAL OF NEURAL TRANSMISSION 399.
Konferenzbeitrag
42 (Suppl. 1), T26, S. S310 - S311 (2017)
Aging- and Stress-Related Epigenetic Disinhibition of FKBP5 Contributes to NF-KB-Driven Inflammation and Cardiovascular Risk. 56th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP), Palm Springs, CA, 03. Dezember 2017 - 07. Dezember 2017. NEUROPSYCHOPHARMACOLOGY Meeting Abstract (27)
400.
Meeting Abstract
31, S. 341 - 341. (2023)
Large-scale genomic meta-analysis on math abilities in cohorts of 20,000 participants. In EUROPEAN JOURNAL OF HUMAN GENETICS,